Two-, three-, and four-dimensional nuclear magnetic resonance spectroscopy of protein pharmaceuticals.
Advances in NMR spectroscopy and related computational methods continue at a rapid pace. In the past three years, the capability to make complete assignments of protein spectra has expanded from a limit of approximately 100 residues to a limit of possibly 400 residues via isotope-edited three- and four-dimensional methods.